000 01788 a2200505 4500
005 20250514181822.0
264 0 _c20040429
008 200404s 0 0 eng d
022 _a0264-410X
024 7 _a10.1016/j.vaccine.2003.10.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBruge, Joëlle
245 0 0 _aClinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers.
_h[electronic resource]
260 _bVaccine
_cMar 2004
300 _a1087-96 p.
_bdigital
500 _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article
650 0 4 _aAdult
650 0 4 _aAnimals
650 0 4 _aAntibodies, Bacterial
_xanalysis
650 0 4 _aAntibody Specificity
650 0 4 _aAutoantibodies
_xanalysis
650 0 4 _aColony Count, Microbial
650 0 4 _aCross Reactions
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aHumans
650 0 4 _aImmunization
650 0 4 _aImmunoglobulin G
_xanalysis
650 0 4 _aImmunoglobulin M
_xanalysis
650 0 4 _aMale
650 0 4 _aMeningococcal Infections
_xprevention & control
650 0 4 _aMeningococcal Vaccines
_xadverse effects
650 0 4 _aMice
650 0 4 _aNeisseria meningitidis, Serogroup B
_ximmunology
650 0 4 _aNeural Cell Adhesion Molecules
_ximmunology
650 0 4 _aPolysaccharides
_ximmunology
650 0 4 _aPrecipitin Tests
650 0 4 _aRats
650 0 4 _aVaccines, Conjugate
_xadverse effects
700 1 _aBouveret-Le Cam, Nancy
700 1 _aDanve, Bernard
700 1 _aRougon, Geneviève
700 1 _aSchulz, Dominique
773 0 _tVaccine
_gvol. 22
_gno. 9-10
_gp. 1087-96
856 4 0 _uhttps://doi.org/10.1016/j.vaccine.2003.10.005
_zAvailable from publisher's website
999 _c14723757
_d14723757